Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Postlinuxeg, MON 07 Jun 2010 
 
Costa Rica puts brakes on popular stem cell tourism
Eisai's breast cancer drug extends lives: study
Nigeria cleans "poisoned" villages, treats children
Children of lesbian couples do well in school, life
Nektar ovarian cancer drug benefits women in study
Roche's Avastin helps ovarian cancer: study
White hair a "healing sign" with melanoma drugs
Meat, fish protein linked to women's bowel disease
Drug fights tumors in advanced lung cancer
Delcath cancer drug delivery system aids survival

Costa Rica puts brakes on popular stem cell tourism
June 07, 2010 01:06 AM ET
SAN JOSE, Costa Rica (Reuters) - Costa Rica is cracking down on an unauthorized stem cell clinic that has attracted hundreds of foreigners seeking relief from degenerative diseases and serious injuries.

Full Article
Eisai's breast cancer drug extends lives: study
June 06, 2010 01:08 PM ET
WASHINGTON (Reuters) - An experimental breast cancer drug made from sea sponges added months to the lives of breast cancer patients whose cancer had come back despite several rounds of chemotherapy, doctors reported Sunday.

Full Article
Nigeria cleans "poisoned" villages, treats children
June 07, 2010 07:29 AM ET
KADUNA, Nigeria (Reuters) - Health workers have set up emergency treatment centers in northern Nigeria for scores of children suffering from lead poisoning and are racing to contain contamination which has already killed more than 160 people.

Full Article
Children of lesbian couples do well in school, life
June 07, 2010 09:45 AM ET
NEW YORK (Reuters Health) - Being raised by a same-sex couple is no hindrance to healthy psychological development, researchers say as the first generation of children conceived by lesbians through donor insemination is coming of age.

Full Article
Nektar ovarian cancer drug benefits women in study
June 06, 2010 06:49 PM ET
CHICAGO (Reuters) - About 48 percent of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics' experimental drug NKTR-102 in a mid-stage study, the company said on Sunday.

Full Article
Roche's Avastin helps ovarian cancer: study
June 06, 2010 02:33 PM ET
CHICAGO (Reuters) - Long-term use of Swiss drugmaker Roche Holding AG's Avastin, in combination with chemotherapy, helped women with advanced ovarian cancer live longer without their cancer getting worse, according to results from a new study.

Full Article
White hair a "healing sign" with melanoma drugs
June 06, 2010 06:20 PM ET
CHICAGO (Reuters) - When your hair turns white it is usually a sign of old age, but in advanced melanoma patients taking a new type of cancer treatment, it may be a very good sign, researchers said on Saturday.

Full Article
Meat, fish protein linked to women's bowel disease
June 04, 2010 09:13 PM ET
NEW YORK (Reuters Health) - Eating lots of animal protein appears to increase women's risk of developing inflammatory bowel disease (IBD), according to a new study from France.

Full Article
Drug fights tumors in advanced lung cancer
June 05, 2010 05:16 PM ET
CHICAGO/NEW YORK (Reuters) - A drug being developed by Pfizer Inc shrank lung cancer tumors in more than half of treated patients, and nearly all showed some benefit, U.S. researchers said on Saturday.

Full Article
Delcath cancer drug delivery system aids survival
June 05, 2010 06:30 PM ET
CHICAGO (Reuters) - A drug delivery system developed by Delcath Systems Inc helped melanoma patients whose cancer had spread to their liver live more than three times as long as patients treated with best available care.

Full Article
 
 











REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague


Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

0 comentários: